Early research (Phase 1)Study completedNCT03254277What this trial is testing3BNC117-LS First-in-Human Phase 1 StudyWho this might be right forHuman Immunodeficiency Virus Rockefeller University 43
Not applicableStudy completedNCT04751643What this trial is testingTherapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 InfectionsWho this might be right forIntensive Care UnitsARDS, HumanCovid19 Hospices Civils de Lyon 21
Not applicableUnknownNCT04716543What this trial is testingEpidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and AnimalsWho this might be right forInfluenza -Like IllnessCovid19 ANRS, Emerging Infectious Diseases 5,400
Not applicableStudy completedNCT04847596What this trial is testingStudy to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabWho this might be right forRelapsing Multiple Sclerosis Novartis Pharmaceuticals 25
Not applicableUnknownNCT04779996What this trial is testingAntibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 TreatmentWho this might be right forCovid19CancerHIV Infections Auxilio Mutuo Cancer Center 250
Post-approval studies (Phase 4)WithdrawnNCT02135666What this trial is testingEvaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)Who this might be right forHepatitis BHepatitis A GlaxoSmithKline
Not applicableStudy completedNCT04741386What this trial is testingThe REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) StudyWho this might be right forCovid19Chronic Kidney Diseases University Medical Center Groningen 854
Not applicableStudy completedNCT04334954What this trial is testingSARS-COV2 Pandemic Serosurvey and Blood SamplingWho this might be right forSARS-COV2 Virus National Institute of Allergy and Infectious Diseases (NIAID) 11,363
Not applicableStudy completedNCT06891170What this trial is testingB Cell Responses in COVID-19Who this might be right forCOVID 19 Fondazione IRCCS Policlinico San Matteo di Pavia 4
Early research (Phase 1)Study completedNCT00000884What this trial is testingPhase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 84
Not applicableStudy completedNCT04837651What this trial is testingHumoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabWho this might be right forMultiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous System+5 more Dragonfly Research, LLC 48
Early research (Phase 1)Study completedNCT04519437What this trial is testingStudy Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19Who this might be right forHealthyChronic Stable Illness Regeneron Pharmaceuticals 974
Testing effectiveness (Phase 2)Study completedNCT00562939What this trial is testingImmune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected AdultsWho this might be right forHIV Infections University of Aarhus 97
Not applicableStudy completedNCT06989307What this trial is testingCOVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)Who this might be right forCOVID-19COVID-19 Serological TestingCOVID-19 Vaccines+3 more Centre Hospitalier de Saint-Denis 447
Not applicableEnded earlyNCT00138320What this trial is testingHerpevac Neonatal SubstudyWho this might be right forHerpes Simplex National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Study completedNCT00886964What this trial is testingHepatitis B Vaccination (HBV) in HIV Infected ChildrenWho this might be right forHIV Infections The HIV Netherlands Australia Thailand Research Collaboration 80
Not applicableStudy completedNCT04469634What this trial is testingAre SARS-CoV-2 Specific Antibodies a Correlate for Protection?Who this might be right forSARS-CoV2COVID-19 Institute of Tropical Medicine, Belgium 150
Early research (Phase 1)Study completedNCT03783130What this trial is testingDose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy AdultsWho this might be right forHuman Immunodeficiency Virus PreventionHuman Immunodeficiency Virus (HIV) National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Study completedNCT05505448What this trial is testingA Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult ParticipantsWho this might be right forHealthy Regeneron Pharmaceuticals 48
Not applicableStudy completedNCT04367740What this trial is testingScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19Who this might be right forAsymptomatic ConditionInfection ViralCoronavirus Infections+5 more University of North Carolina, Chapel Hill 6,313